Heated Milk Desensitization Shows No Benefit and Higher Anaphylaxis Risk in Cow’s Milk Allergy: Study

A small prospective, double-blind study in children with IgE-mediated cow’s milk allergy (CMA) found that heated cow’s milk desensitization offers no clear immunologic advantage over conventional raw milk oral immunotherapy.…

Continue ReadingHeated Milk Desensitization Shows No Benefit and Higher Anaphylaxis Risk in Cow’s Milk Allergy: Study

Neighborhood Disadvantage Limits Access to Kidney Transplantation, Finds JAMA Study

USA: A recent cohort study examining adults with End-Stage Kidney Disease (ESKD) and kidney transplant (KT) candidates found that living in highly disadvantaged neighborhoods significantly limits access to life-saving treatments. …

Continue ReadingNeighborhood Disadvantage Limits Access to Kidney Transplantation, Finds JAMA Study

Acupuncture targets mast cells and inflammatory cascade to reduce allergic disorders: Study

A new study published in the International Journal of General Medicine showed that by focusing on mast cells and inflammatory cascades, acupuncture reduces allergic diseases, demonstrating its promise as a…

Continue ReadingAcupuncture targets mast cells and inflammatory cascade to reduce allergic disorders: Study

Correlation between cancer cachexia and immune-related adverse events in HCC: Study

Immune checkpoint inhibitors (ICIs), including antibodies against the programmed cell death protein 1/ligand 1 (PD-1/L1) effectively at boost the immune system; however, they may cause immune-related adverse events (irAEs). The…

Continue ReadingCorrelation between cancer cachexia and immune-related adverse events in HCC: Study

High-Dose HCQ Tied to Better Symptom Control in SLE With Lower Adverse CV Events: Study

Taiwan: Analysis of national data from Taiwan shows that hydroxychloroquine (HCQ), despite known long-term risks such as retinopathy, remains a cornerstone of lupus treatment. In patients with systemic lupus erythematosus…

Continue ReadingHigh-Dose HCQ Tied to Better Symptom Control in SLE With Lower Adverse CV Events: Study

SGLT2 Inhibitors Provide Broad Benefits in Kidney Outcomes Across Diabetes Status and UACR Levels: JAMA

A major pooled analysis published in JAMA has shown that sodium-glucose cotransporter 2 (SGLT2) inhibitors deliver consistent kidney and cardiovascular benefits across different patient groups—irrespective of diabetes status or baseline…

Continue ReadingSGLT2 Inhibitors Provide Broad Benefits in Kidney Outcomes Across Diabetes Status and UACR Levels: JAMA